Radiopharm Theranostics, a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that it has...
Cambrian Biopharma, a multi-asset longevity biotech, announced a licensing agreement with Novartis to advance novel, selective compounds designed and characterized by Novartis to target...
